Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
BMC Medicine|May 12, 2024
Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness MethodVita Brisnik, Jochen Vukas, Caroline Jung-Sievers, et al.
BMJ Open Quality|June 30, 2025
Interventions to improve patient safety during the COVID-19 pandemic: a systematic reviewAlbert W Wu, Katelyn Trigg, Allen Zhang, et al.
JAMA Network Open|January 16, 2019
Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private InsurersJames Heyward, Christopher M Jones, Wilson M Compton, et al.
Diabetes Care|October 25, 2022
Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and IsraelBeini Lyu, Yingying Sang, Elizabeth Selvin, et al.
Annals of Internal Medicine|August 16, 2021
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort StudyHemalkumar B Mehta, Huijun An, Kathleen M Andersen, et al.
Journal of Alzheimer'S Disease : JAD|April 11, 2022
Making the Case for Accelerated Withdrawal of AducanumabPeter Whitehouse, Sam Gandy, Vikas Saini, et al.
The Lancet. Rheumatology|November 22, 2021
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort CollaborativeKathleen M Andersen, Benjamin A Bates, Emaan S Rashidi, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2022
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort studyKathleen M Andersen, Corey S Joseph, Hemalkumar B Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Plos Medicine|January 17, 2025
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Pageof 37